COVID-19 Global Market Conditions: Cell Therapies, Diagnostics, Treatments, Trials, and Vaccines
Flash Sale for 75% Off (48 Hours Only) Expires Friday, July 24, 2020, at Midnight
|
| |
Recently released, this July 2020 global strategic report provides comprehensive coverage of the rapidly evolving COVID-19 pandemic, with an emphasis on the emerging role of cell therapies in the prevention and management of the COVID-19.
Globally, the healthcare industry is using every weapon in its armory to suppress the threat from the virus, including the use of living therapies such as natural killer (NK) cells, T cells, stem cells, and exosomes. While many novel approaches are being investigated, stem cells – mesenchymal stem cells (MSCs) in particular – are showing intriguing potential for the treatment of COVID-19 related complications.
This 269-page market report reveals every known cell therapy, diagnostic, treatment, and vaccine in development worldwide. It reveals trend rate data for COVID-19 scientific publications, patents, and clinical trials on a worldwide basis. With the rapidly developing nature of this global pandemic, claim this global strategic report to become immediately informed about COVID-19 market dynamics and position your company for success during this historic time.
For 48 hours only, you can claim this report for 75% off:
Be Great, BioInformant Team
p.s. Remember to act fast, because this offer expires Friday, July 24, at midnight.
|
|
|
